Company* |
Company |
Type/Product Area |
Terms/Details (Date) |
BioE Inc.* |
Phillips Plastics Corp. |
Collaboration to develop and commercialize stem cell therapeutics for orthopedic applications |
The therapeutics will consist of BioE's Multi-Lineage Progenitor Cell stem cell derived from human umbilical cord blood, and Phillips Plastics' growth structures (5/21) |
|
|
|
|
Cytori Therapeutics Inc. (CYTX) |
Kensey Nash Corp. |
Agreement under which Cytori sold its Hydrosorb surgical implant product line, part of its MacroPort Biosurgery division, for $3.2M |
The line includes spine and orthopedic implants that will now be manufactured by Kensey Nash (6/1) |
|
|
|
|
Senopsys LLC* |
Patheon Inc. (Canada; TSX:PTI) |
Collaboration to accelerate the development of palatable drug products |
Senopsys will have access to prototype drug formulations manufactured by Patheon, which will offer its clients taste assessment and optimization services (6/19) |
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
TSX = Toronto Stock Exchange. | |||
To read more on related topics, click on one of the words below.